Senior insider sale
EVP & Chief Financial Officer at ENCOMPASS HEALTH CORP — senior position signals high conviction
$5.32M
46.56K shares
What this filing means
COLTHARP DOUGLAS E plans to sell 46.56K shares of ENCOMPASS HEALTH CORP valued at approximately $5.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001969223-26-000876
Officer· EVP & Chief Financial Officer
Since Feb 2026
46.56K
Shares to sell
$5.32M
Approx. market value
18.87K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months5
RSA Vesting
N/A
2/28/2025
973.00RSA Vesting
N/A
2/25/2025
1.35KRSA Vesting
N/A
2/23/2025
1.16KRSA Vesting
N/A
1/1/2025
8.31KRSA Vesting
N/A
1/1/2025
7.08KTotal acquired18.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2025 | RSA Vesting N/A | 973.00 | — |
2/25/2025 | RSA Vesting N/A | 1.35K | — |
2/23/2025 | RSA Vesting N/A | 1.16K | — |
1/1/2025 | RSA Vesting N/A | 8.31K | — |
1/1/2025 | RSA Vesting N/A | 7.08K | — |
| Total | 18.87K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
27.69K
Market value
$2.96M
5/15/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
18.87K
Market value
$2.37M
8/10/2026
Total
Units
46.56K
Value
$5.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 27.69K | $2.96M | — | Completed |
| Planned — Approximate Date | ||||
8/10/2026 | 18.87K | $2.37M | NYSE | Planned |
| Total | 46.56K | $5.32M | ||